Giulia Benevolo

29PUBLICATIONS
124CO-AUTHORS
Predictive and prognostic markersMedical mycologyAutoimmunityHaematological tumoursMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 11, 2026
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.

|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.

|Mar 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 13, 2026
Survival and quality-of-life implications of cytopenia trajectories in ruxolitinib-treated myelofibrosis.

Francesca Palandri, Giovanni Caocci, Elisabetta Abruzzese

|Aug 21, 2025
Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib.

Francesca Palandri, Filippo Branzanti, Massimiliano Bonifacio

Pageof 5

Frequent Collaborators

15 joint publications

Francesca Palandri

14 joint publications

Massimo Breccia

13 joint publications

Mario Tiribelli

12 joint publications

Alessandra Iurlo